Evidence map›Paper›PMID 18799728›Full record

ArticleBlood2008

IRF8 regulates B-cell lineage specification, commitment, and differentiation.

Hongsheng Wang, Chang Hoon Lee, Chenfeng Qi, Prafullakumar Tailor, Jianxun Feng, Sadia Abbasi, Toru Atsumi, Herbert C Morse

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 1 synthesis or guideline pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Circulating IRF8-expressing CD123Trends in immunology · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. The Role of mInternational journal of molecular sciences · 2023
    Review
  19. Article
  20. Alzheimer's Disease: From Immune Homeostasis to Neuroinflammatory Condition.International journal of molecular sciences · 2022
    Review

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hongsheng WangLaboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. wanghongs@niaid.nih.gov
Chang Hoon Lee
Chenfeng Qi
Prafullakumar Tailor
Jianxun Feng
Sadia Abbasi
Toru Atsumi
Herbert C Morse
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health · US

Funding

Molecular Regulation of B-Cell Differentiation and FunctionZIAAI001024 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MORSE, HERBERT · 2009 to 2018
$8.3M
Molecular Regulation of B-Cell Differentiation and FunctionZ01AI001024 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI MORSE, HERBERT · 2007 to 2008
$2.2M
Intramural NIH HHS
6 · The paper itself

Abstract

PU.1, IKAROS, E2A, EBF, and PAX5 comprise a transcriptional network that orchestrates B-cell lineage specification, commitment, and differentiation. Here we identify interferon regulatory factor 8 (IRF8) as another component of this complex, and show that it also modulates lineage choice by hematopoietic stem cells (HSCs). IRF8 binds directly to an IRF8/Ets consensus sequence located in promoter regions of Sfpi1 and Ebf1, which encode PU.1 and EBF, respectively, and is associated with transcriptional repression of Sfpi1 and transcriptional activation of Ebf1. Bone marrows of IRF8 knockout mice (IRF8(-/-)) had significantly reduced numbers of pre-pro-B cells and increased numbers of myeloid cells. Although HSCs of IRF8(-/-) mice failed to differentiate to B220(+) B-lineage cells in vitro, the defect could be rescued by transfecting HSCs with wild-type but not with a signaling-deficient IRF8 mutant. In contrast, overexpression of IRF8 in HSC-differentiated progenitor cells resulted in growth inhibition and apoptosis. We also found that IRF8 was expressed at higher levels in pre-pro-B cells than more mature B cells in wild-type mice. Together, these results indicate that IRF8 modulates lineage choice by HSCs and is part of the transcriptional network governing B-cell lineage specification, commitment, and differentiation.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsB-LymphocytesCell DifferentiationHematopoietic Stem CellsIkaros Transcription FactorInterferon Regulatory Factor-8Interferon Regulatory FactorsLeukocyte Common AntigensMiceMice, KnockoutPAX5 Transcription FactorProtein BindingProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Response ElementsBasic Helix-Loop-Helix ProteinsEbf1 protein, mouseIkaros Transcription FactorInterferon Regulatory Factor-8Interferon Regulatory FactorsLeukocyte Common AntigensPax5 protein, mousePAX5 Transcription FactorProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Tcf3 protein, mouseTrans-ActivatorsZfpn1a1 protein, mouse

Identifiers

PMID18799728
PMCPMC2581985
OpenAlexW2076477779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.